Sage Therapeutics (SAGE) PT Lowered to $48 at Guggenheim
Get Alerts SAGE Hot Sheet
Price: $8.68 --0%
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Guggenheim analyst Yatin Suneja lowered the price target on Sage Therapeutics (NASDAQ: SAGE) to $48.00 (from $55.00) while maintaining a Buy rating.
You May Also Be Interested In
- JPMorgan Downgrades Bukit Asam Tbk PT (PTBA:IJ) to Underweight
- Brinker Int'l (EAT) PT Lowered to $240 at DA Davidson Ahead of Analyst Day
- Visual Photonics Epitaxy Co Ltd (2455:TT) PT Raised to NT$846 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share